FGF21 and metabolic dysfunction-associated steatotic liver disease: Another study measured FGF21 levels by ELISA in 82 patients with biopsy-confirmed NAFLD and in 77 control subjects and subsequently analyzed the association between FGF21 and NAFLD patient characteristics using multiple linear regression analysis.